They proposed that the interaction between JAK3 and RNA Polymerase II was a result of JAK3 interaction with the Histone methyl transferase EZH2, however, we could not find JAK3 interaction with EZH2 in CTCL (data not shown). This evidence concerns the gene JAK3 and primary cutaneous T-cell non-Hodgkin lymphoma.